Maintaining a healthy diet is essential for preventing chronic conditions such as diabetes, obesity, and cardiovascular diseases. Traditional methods of tracking food intake often involved
In this week’s patent roundup, we present some of the most notable patents and applications filed or granted recently. This edition features advancements such as
Artificial intelligence is transforming healthcare through groundbreaking technologies in diagnostics and patient care. Ellipsis Health’s speech-based AI system offers real-time mental health insights, while 4bases’
As we celebrate Pride Month, it’s crucial to recognize the LGBTQIA+ individuals who have made and continue to make significant contributions in the scientific community.
Gene therapy is revolutionizing cancer treatment, offering innovative approaches to target and eradicate cancer cells at the genetic level. As of June 2024, the U.S.
The gene therapy sector is poised to deliver groundbreaking treatments for various diseases. In this article, we explore gene therapy startups and their patents.
Gene therapy offers a revolutionary approach to treating genetic disorders by introducing healthy genetic material into a patient’s cells.
In 2023, 19 Biotech companies launched IPOs in the US. We take a look at their patenting activity and the technologies they cover.
As healthcare is becoming increasingly data-driven, we can expect that the use of AI, specifically machine learning.
Following our earlier article, we look at recent patents and patent applications in the hyperautomation space.
Services
Links
Sign up to receive first access to our reports, the latest patent news, and other updates —
all delivered to your inbox.
Sign up now to receive monthly patent news, analysis and free insight reports.
We don’t spam, we promise.
Disclaimer:
1. Parola Analytics and Avontis are distinct entities and operate independently. Any references to Avontis or its services do not constitute a legal partnership.
2. Parola Analytics does not provide legal services. Our services are limited to research and technical analysis. Any information provided by Parola Analytics should not be construed as legal advice.